The Cook® Zilver® 635™ Biliary Stent is indicated for use in palliation of malignant neoplasms in the biliary tree.
Device Story
Self-expanding nitinol stent; designed for radial strength and longitudinal flexibility. Construction: interconnected Z-shaped segments providing circumferential scaffolding. Features gold radiopaque markers at stent ends and delivery system distal end for positioning. Preloaded in 6 French delivery system; deployed via handheld device. Available in various diameters (4-14 mm) and lengths (20-80 mm). Used in biliary tree to palliate malignant neoplasms. Physician-operated. Stent conforms to biliary anatomy; provides scaffolding to maintain patency. Benefits patient by relieving biliary obstruction caused by malignancy.
Clinical Evidence
Bench testing only. Tests included deployment profile, deployment accuracy, stent length/diameter changes, uniformity of expansion, stent integrity, and radial force.
Technological Characteristics
Self-expanding nitinol stent; interconnected Z-shaped segments; gold radiopaque markers. Delivery system: 6 French. Available diameters: 4-14 mm; lengths: 20-80 mm. Mechanical device; no software or energy source.
Indications for Use
Indicated for palliation of malignant neoplasms in the biliary tree.
Regulatory Classification
Identification
A biliary catheter and accessories is a tubular flexible device used for temporary or prolonged drainage of the biliary tract, for splinting of the bile duct during healing, or for preventing stricture of the bile duct. This generic type of device may include a bile collecting bag that is attached to the biliary catheter by a connector and fastened to the patient with a strap.
Special Controls
*Classification.* Class II (special controls). The device, when it is a bile collecting bag or a surgical biliary catheter that does not include a balloon component, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.
Related Devices
K080037 — MODIFICATION TO ZILVER 635 BILIARY STENT · Cook, Inc. · Aug 1, 2008
K031821 — MODIFICATION TO COOK ZILVER BILIARY STENT · Cook, Inc. · Jul 18, 2003
K042518 — ZILVER 518 BILIARY STENT · Cook, Inc. · Oct 1, 2004
K043481 — MODIFICATION TO: ZILVER 635 BILIARY STENT · Cook, Inc. · Dec 29, 2004
K033348 — ZILVER 518 BILIARY STENT · Cook, Inc. · Dec 15, 2003
Submission Summary (Full Text)
{0}------------------------------------------------
Special 510(k) Premarket Notification Cook Zilver® 635™ Biliary Stent COOK INCORPORATED
## 510(k) Summary
JUL 1 2 2005
53
KC51124
Page 1 of 2
# Submitted By:
Stephanie Roberts Regulatory Affairs Cook Incorporated 750 Daniels Way, PO Box 489 Bloomington, IN 47402 812-339-2235
Mav 2, 2005
#### Device:
Trade Name: Proposed Classification: Zilver® 635" Biliary Stent Catheter, Biliary, Diagnostic
#### Predicate Devices:
The Zilver® 635™ Biliary Stent is similar in terms of intended use, materials of construction and technological characteristics to predicate devices reviewed as devices for palliation of malignant neoplasm in the biliary tree.
#### Device Description:
The Zilver® 635 " Biliary Stent is a self-expanding, nitinol stent designed for excellent radial strength and optimal longitudinal flexibility. Constructed from a series of interconnected Z-shaped segments, the stent conforms to the shape of the biliary system and provides circumferential scaffolding throughout the stent's length. Gold radiopaque markers on each end of the Zilver® 635™ Biliary Stent, along with one radiopaque marker at the distal end of the delivery system, allow precise positioning of the stent. The stent's interconnected Z-shaped segments also keep foreshortening to a minimum.
The Zilver® 635" Biliary Stent comes preloaded in a 6 French delivery system. The stent is deployed with the use of a simple hand held device. The stent is available in unrestrained outer diameters of 4, 5, 6, 7, 8, 9 and 10 mm and in lengths of 20, 30, 40, 50, 60 and 80 mm. The 9, 10, 12, and 14 mm diameter stent with a cannula outside diameter of 1.6 mm is an addition to this product line.
### Substantial Equivalence:
This device will be manufactured according to specified process controls and a Quality Assurance Program. This device will undergo packaging similar to the
{1}------------------------------------------------
Special 510(k) Premarket Notification Cook Zilver® 635™ Biliary Stent COOK INCORPORATED
54 K051124
Page 2 of 2
s
predicate devices currently marketed and distributed by Cook Incorporated. This predicate devices carrerilization similar to the predicate devices currently device will andergo otonilea.org similar with respect to indications for use, materials and distribution "Boing online and predicate devices, this device meets the requirements for section 510(k) substantial equivalence.
# Test Data:
-
The Zilver® 635™ Biliary Stent was subjected to the following tests to assure reliable design and performance under the specified testing parameters. These tests were comprised of:
- Deployment 1.
- a. Profile
- b. Deployment Accuracy
- c. Stent length and Change due to Deployment
- d. Stent Diameter
- e. Uniformity of Expansion
- Stent Integrity ﮩﻨ
- 2. Radial Force
The results of these tests provide reasonable assurance that the device has The results of these tests provide reaconaments for the requirements for its use as a biliary stent.
. . . -
{2}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of an eagle with three lines representing its wings and body.
#### Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUL 12 2005
...
Ms. Stephanie Roberts Regulatory Affairs Specialist Cook Incorporated 750 Daniels Way P.O. Box 489 BLOOMINGTON IN 47402-0489
Re: K051124
K031124
Trade/Device Name: Cook® Zilver® 633TM Biliary Stent Regulation Number: 21 CFR §876.5010 Regulation Name: Biliary catheter and accessories Regulatory Class: II Product Code: FGE Dated: July 5, 2005 Received: July 6, 2005
Dear Ms. Roberts:
We have reviewed your Section 510(k) premarket notification of intent to market the device We have reviewed your Section 310(t) promatic is substantially equivalent (for the indications
referenced above and have determined the device is subsessmarketed in interstat referenced above and have delemined the device to redicate devices marketed in interstate for use stated in the enclosure) to regally manced promoted Device American so to
commerce prior to May 28, 1976, the enactment date of the Federal Food. Drug commerce prior to May 28, 1970, the chaodinene with the provisions of the Federal Food, Drug, devices that have been reclassified in accounted the device, subject to the general controls provisions of the and Cosmetic Act (Act). You may, therefore, therefore, The general controls provisions of the provisions of the Act and the immantous described of devices, good manufacturing practice, Act merude requireme against misbranding and adulteration.
The Office of Device Evaluation has determined that there is a reasonable likelihood that this The Office of Device Evaluation has decemined that the proposed labeling and that such use device will be used for an mended use not neith Section of S(i)(L)(E) of the Act, the following Could Cause nami. "Therefee, Warnings section of the device's labeling:
The safety and effectiveness of this device for use in the vascular system have not been established.
Furthermore, the indication for biliary use must be prominently displayed in all labeling, Furthermore, the Includion for othary use must of promotions for use, and other promotional materials, in metuding pouch, box, and carvone, of a similar point size, and in bold print.
{3}------------------------------------------------
# Page 2 – Ms. Stephanie Roberts
Please note that the above labeling limitations are required by Section 513(i)(1)(E) of the Act. Please note that the a00ve tabeling innitations are modified in any way or removed from the device's labeling.
The FDA finding of substantial equivalence of your device to a legally marketed predicate THE IDA Iniding of substantial equirae and permits your device to proceed to the device results in a classification for your device as described in your Section market. This letter will anow you to eventimation statement described above is added to your labeling.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), If your device is classified (000 above) and stations affecting your device can be it may be subject to additional controliations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean Please be advised that FDA s issumes of a bacements of the requirements of the Act that I DA has made a decormination administered by other Federal agencies. You must or any irederal statutes and regalations and limited to: registration and listing (21 comply with an the Act 3 requirements, morading, can manufacturing practice requirements as set CFK Fart 807), labeling (21 CFR Part 820); and if applicable, the electronic forth in the quality systems (QD) regulations (Sections 531-542 of the Act); 21 CFR 1000-1050.
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000
If you desire specific information about the application of other labeling requirements to your II you desire specific information acourt the Office of Compliance at (240) 276-0115. Also, uevice (21 CFRT an 001), preference to premarket notification' (21 please note the regulation onlines and information on your responsibilities under the CITY att 807.77). Tou may obtain official general, and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.
Sincerely yours
Donna-Bea Tillman, Ph.D. Director Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
# Indications for Use
510(k) Number (if known): K051124
Device Name: Cook® Zilver® 635™ Biliary Stent
-
Indications For Use:
The Cook® Zilver® 635™ Biliary Stent is indicated for use in palliation of malignant neoplasms in the biliary tree.
Prescription Use _____________________________________________________________________________________________________________________________________________________________
AND/OR
Over-The-Counter Use
(Part 21 CFR 801 Subpart D)
(21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Nancy C brogdon
Division Sign-Off Division of Reproductive, Abdor and Radiological De 510(k) Number
Page 1 of _1_
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.